Calcium

Calcium

SCHEMBL4738406

CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(O)n1CCCCCC(O)C(=O)O.[Ca]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 5/20 0.48
SLCO1B1 Q9Y6L6 4/20 0.48
ABCB11 O95342 3/20 0.48
HDAC2 Q92769 3/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
NR1I2 O75469 1/20 0.48
RHOC P08134 1/20 0.48
CYP3A4 P08684 1/20 0.48
THRB P10828 1/20 0.48
NR1H4 Q96RI1 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
ABCC3 O15438 2/20 0.47
ABCC4 O15439 2/20 0.47
SLCO1B3 Q9NPD5 2/20 0.47
PDE6D O43924 3/20 0.43
ABCB1 P08183 1/20 0.41
ABCC2 Q92887 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433488 0.99 HMGCR (0.49) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL30668287 0.94 SLCO1B1 (0.49) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL30668286 0.94 SLCO1B1 (0.49) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL30668285 0.94 SLCO1B1 (0.49) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL29804644 0.90 SLCO1B1 (0.51) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL7080939 0.90 SLCO1B1 (0.51) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL18051134 0.90 HMGCR (0.53) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL29795041 0.83 SLCO1B1 (0.51) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL6100481 0.74 SLCO1B1 (0.45) HMGCRSLCO1B1ABCB11HDAC2HDAC1
SCHEMBL3611017 0.73 HMGCR (0.77) HMGCRSLCO1B1ABCB11HDAC2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110913843-B Pharmaceutical composition 伊莱利利公司 2022-09-13 CN disclosed
CN-110913843-A Pharmaceutical composition 伊莱利利公司 2020-03-24 CN disclosed
WO-2008075165-A1 NOVEL PROCESS FOR THE SYNTHESIS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF PFIZER PRODUCTS INC. (US) 2008-06-26 WO disclosed
WO-2006123358-A2 STABILIZED ATORVASTATIN-CONTAINING FORMULATION SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2006-11-23 WO disclosed